Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.
The pharma signed an agreement handing PE firm CD&R a 50% stake in its Capella unit. Elsewhere, Gilead and Ultragenyx secured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback